Disclosure of trading in own shares occurred on March 30, 2026 Puteaux, April 2, 2026 In accordance with the regulations on share buybacks, in particular Regulation (EU) 2016/1052, Elis hereby declares the purchases of its own shares made on March 30, 2026 under the buyback program authorized by the 24th resolution of the General Shareholders’ Meeting of May 22, 2025: Aggregated presentation:Issuer name Issuer code(LEI) Transaction date ISIN Code Daily total Volume (in number of shares) Daily weighted average price of shares acquired (in euros) Platform (MIC Code)ELIS SA 969500UX71LCE8MAY492 3/30/2026 FR0012435121 79,600 24.2188 XPARELIS SA 969500UX71LCE8MAY492 3/30/2026 FR0012435121 73,336 24.2763 DXEELIS SA 969500UX71LCE8MAY492 3/30/2026 FR0012435121 12,000 24.2308 TQEELIS SA 969500UX71LCE8MAY492 3/30/2026 FR0012435121 14,500 24.1690 AQE  Total 179,436 24.2391          The...

Invitation to the ordinary General Meeting of Shareholders of Fenix Outdoor International AG The Board of Directors is pleased to invite you to the ordinary General Meeting concerning the financial year 2025. Date:         Monday, 27 April 2026, 2 pmPlace:        Hemvärnsgatan 9, Solna (Sweden)                             I.      Notification Shareholders who wish to attend (in person, representation by proxy or by the Independent Proxy) the ordinary General Meeting must be recorded in the Company’s share register by Friday, 17 April 2026 at the latest and must notify the Company no later than Tuesday, 21 April 2026, 1 p.m. by telephone +46 660 26 62 00, by mail to Fenix Outdoor International AG, Solna Strandvag 128 B, 171 54 Solna (Sweden) or by e-mail info@fenixoutdoor.se of their attendance. An e-mail from the Company confirming...

Please find below a press release from Aedifica (a public regulated real estate company under Belgian law, listed on Euronext Brussels and Euronext Amsterdam), regarding the Extraordinary General Meeting and Ordinary General Meeting of Tuesday 12 May 2026.AttachmentsPress Release ENCommuniqué de presse FRPersbericht NL

Millicom prices reopening of $75 million of 7.375% Senior Notes Due 2032 Luxembourg, April 2, 2026 – Millicom International Cellular S.A. (“Millicom”) (NASDAQ US, TIGO) announces today the successful pricing of $75 million aggregate principal amount of its 7.375% Senior Notes due 2032 (the “Additional Notes”) in a Regulation S only tap private placement to an investor that is not a “U.S. Person” (as defined in Regulation S under the U.S. Securities Act of 1933, as amended (the “Securities Act”)) at a price of 100.985%, plus accrued and unpaid interest from and including April 2, 2026 to, but excluding, the issue date of the Additional Notes. The Additional Notes will be issued as a reopening of, and will be part of the same series as, the 7.375% Senior Notes due 2032 that Millicom originally issued on April 2, 2024 (the “Initial Notes”...

HAMPTON, N.J., April 01, 2026 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX) today announced the pricing of an underwritten public offering of 10,345,000 shares of its common stock at a public offering price of $29.00 per share. All of the shares to be sold in the offering are to be sold by Celldex. In connection with the offering, Celldex has also granted the underwriters a 30-day option to purchase up to an additional 1,551,750 shares of common stock at the public offering price, less the underwriting discounts and commissions. The Company expects to receive gross proceeds from the offering, excluding the exercise of the underwriters’ option, if any, of approximately $300 million, excluding the underwriting discounts and commissions and other offering-related expenses. The offering is...

TORONTO, April 01, 2026 (GLOBE NEWSWIRE) — Trisura Group Ltd. (“Trisura” or “Trisura Group”) (TSX: TSU), a leading specialty insurance provider, today announced the appointment of Chris Sekine to its Board of Directors and the retirement of Robert Taylor. In addition, Trisura today announced that Chris Sekine is expected to stand for election to the Board of Directors at this year’s Annual Meeting of Shareholders. Mr. Taylor served as the Chairman and a director of Trisura Guarantee Insurance Company from 2013 to 2017. As a co-founder of Trisura Guarantee Insurance Company, Mr. Taylor served as the CEO of the company from its inception in 2006 until 2012. Mr. Sekine served as President and CEO of Trisura Guarantee Insurance Company from 2018 to 2024 and has been with the Company since its inception in 2006 when he established the...

MELBOURNE, Australia and INDIANAPOLIS, April 02, 2026 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces the appointment of David Gill as a Non-Executive Director (NED), as part of Board expansion and succession planning. The appointment is effective May 11, 20261. Mr. Gill is expected to be appointed as Chair in due course, succeeding Dr. Mark Nelson who will remain on the Board as a NED. Mr. Gill is a life sciences executive with over 35 years’ experience in senior general management and financial leadership roles across commercial and clinical-stage biopharmaceutical (including radiopharmaceuticals) and medical device companies. He currently serves on the boards of Evolus, Inc. (NASDAQ: EOLS), Allucent LLC, Bridge to Life Ltd, RapidPulse Inc. and huMannity Medtec (formerly Alfred...

BEIJING, April 01, 2026 (GLOBE NEWSWIRE) — JD.com, Inc. (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter), the “Company” or “JD.com”), a leading supply chain-based technology and service provider, today announced the pricing of its offering of CNY10 billion aggregate principal amount of CNY-denominated senior unsecured notes (the “Notes”). The Notes were offered in offshore transactions outside the United States to certain non-U.S. persons (the “Notes Offering”) in reliance on Regulation S under the United States Securities Act of 1933, as amended (the “Securities Act”). The Notes Offering consists of CNY7.5 billion of 2.05% notes due 2031 and CNY2.5 billion of 2.75% notes due 2036. The Company expects to close the Notes Offering on or about April 10, 2026, subject to the satisfaction of customary closing conditions. The...